secwatch.observer — SEC 8-K summary
======================================

Issuer:     DAVITA INC. (DVA)
CIK:        0000927066
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0000927066-26-000060
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DaVita Q1 2026 adj EPS $2.87 vs $2.00 YoY; revenue $3.416B, repurchased 3M shares
--------------------------------------------------------------------------------

- GAAP and adjusted diluted EPS $2.87, up 44% YoY from $2.00; down sequentially from $3.40 in Q4 2025.
- Consolidated revenue $3.416B; operating income $482M; operating cash flow $321M; free cash flow $140M.
- Repurchased 3.0M shares at avg price $133.70 per share during Q1 2026.
- CEO Javier Rodriguez highlighted clinical excellence and durable results; net income from continuing ops $198M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927066/000092706626000060/0000927066-26-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927066/000092706626000060/dva-20260505.htm
  HTML page:      https://secwatch.observer/filing/0000927066-26-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer